Charity Fund (“Charity Fund”) announced its continued support for elite a (EdUHK) for the third consecutive year. The ...
In the ever-changing global market environment, it is a must to navigate the business with holistic planning and execution of ...
The Honda Next Generation Fuel Cell Module unveiled today is being independently developed by Honda as a successor to the ...
Reflecting these positive developments, Goldman Sachs has raised its 12-month target price for Everest Medicines to HK$48.32, nearly doubling from the previous HK$24.50. The upgrade factors in ...
GoDaddy Airo: An AI-Powered Revolutionary Solution for Asian Entrepreneurs and Small Business Owners
Selina Bieber, Vice President for International Markets at GoDaddy, emphasized the new experience’s significance, "GoDaddy ...
NEC Orchestrating Future Fund(1), an ecosystem-based corporate venture capital (CVC) fund, has invested in Aetion, Inc.(2), a U.S.-based pro ...
This year’s twin jewellery shows are bringing together some 4,000 exhibitors from more than 40 countries and regions - Nearly ...
The Indonesia Economic Summit (IES) 2025 officially opened today in Jakarta, attended by more than 1,500 participants from 48 countries. The two-day summit (Feb 18-19), organized by the Indonesian ...
香港, 2025年2月19日 - (亚太商讯) - 日清食品（香港）慈善基金 （「慈善基金」）宣布连续第三年支持香港教育大学（「教大」）精英运动员，并举行2024/2025 ...
香港, 2025年2月19日 - (亞太商訊) - 日清食品（香港）慈善基金 （「慈善基金」）宣布連續第三年支持香港教育大學（「教大」）精英運動員，並舉行2024/2025 ...
香港, 2025年2月19日 - (亞太商訊) - ...
香港, 2025年2月19日 - (亚太商讯) - 近日，高盛发布了最新的中国生物医药行业深度研究报告，持续看好医疗健康板块中的生物科技领域，并指出部分领先企业将在2025至2026年迎来盈亏平衡的重要节点。其中，云顶新耀（1952.HK）凭借其在肾病、自身免疫及抗感染领域的创新成果和卓越的商业化能力，获得高盛的高度认可。基于公司增长可见度的提升，高盛将其目标价从24.5港元上调至48.32港元， ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback